Follow
Prof. Jan Philipp Radtke
Prof. Jan Philipp Radtke
University Hospital Düsseldorf
Verified email at med.uni-duesseldorf.de
Title
Cited by
Cited by
Year
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
26322018
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
FL Giesel, B Hadaschik, J Cardinale, J Radtke, M Vinsensia, W Lehnert, ...
European journal of nuclear medicine and molecular imaging 44, 678-688, 2017
5402017
Multiparametric magnetic resonance imaging (MRI) and MRI–transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen
JP Radtke, C Schwab, MB Wolf, MT Freitag, CD Alt, C Kesch, ...
European urology 70 (5), 846-853, 2016
2952016
Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment
P Schelb, S Kohl, JP Radtke, M Wiesenfarth, P Kickingereder, ...
Radiology 293 (3), 607-617, 2019
2662019
The value of PSA density in combination with PI-RADS™ for the accuracy of prostate cancer prediction
FA Distler, JP Radtke, D Bonekamp, C Kesch, HP Schlemmer, ...
The Journal of urology 198 (3), 575-582, 2017
2332017
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion …
JP Radtke, TH Kuru, S Boxler, CD Alt, IV Popeneciu, C Huettenbrink, ...
The Journal of urology 193 (1), 87-94, 2015
2242015
Radiomic machine learning for characterization of prostate lesions with MRI: comparison to ADC values
D Bonekamp, S Kohl, M Wiesenfarth, P Schelb, JP Radtke, M Götz, ...
Radiology 289 (1), 128-137, 2018
1972018
Combined clinical parameters and multiparametric magnetic resonance imaging for advanced risk modeling of prostate cancer—patient-tailored risk stratification can reduce …
JP Radtke, M Wiesenfarth, C Kesch, MT Freitag, CD Alt, K Celik, F Distler, ...
European urology 72 (6), 888-896, 2017
1762017
Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
MT Freitag, JP Radtke, BA Hadaschik, A Kopp-Schneider, M Eder, ...
European journal of nuclear medicine and molecular imaging 43, 70-83, 2016
1692016
Adversarial networks for the detection of aggressive prostate cancer
S Kohl, D Bonekamp, HP Schlemmer, K Yaqubi, M Hohenfellner, ...
arXiv preprint arXiv:1702.08014, 2017
1532017
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI …
MT Freitag, JP Radtke, A Afshar-Oromieh, MC Roethke, BA Hadaschik, ...
European journal of nuclear medicine and molecular imaging 44, 776-787, 2017
1492017
Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous …
NL Hansen, C Kesch, T Barrett, B Koo, JP Radtke, D Bonekamp, ...
BJU international 120 (5), 631-638, 2017
1342017
Impact of complete bladder neck preservation on urinary continence, quality of life and surgical margins after radical prostatectomy: a randomized, controlled, single blind trial
JN Nyarangi-Dix, JP Radtke, B Hadaschik, S Pahernik, M Hohenfellner
The Journal of urology 189 (3), 891-898, 2013
1162013
Intraindividual comparison of 18F-PSMA-1007 PET/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of …
C Kesch, M Vinsensia, JP Radtke, HP Schlemmer, M Heller, E Ellert, ...
Journal of Nuclear Medicine 58 (11), 1805-1810, 2017
1082017
Intraindividual comparison of 18F-PSMA-1007 PET/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of …
C Kesch, M Vinsensia, JP Radtke, HP Schlemmer, M Heller, E Ellert, ...
Journal of Nuclear Medicine 58 (11), 1805-1810, 2017
1082017
Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer
A Borkowetz, I Platzek, M Toma, M Laniado, G Baretton, M Froehner, ...
BJU international 116 (6), 873-879, 2015
872015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion …
JP Radtke, S Boxler, TH Kuru, MB Wolf, CD Alt, IV Popeneciu, ...
Prostate cancer and prostatic diseases 18 (3), 288-296, 2015
852015
“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
J Grummet, MA Gorin, R Popert, T O’Brien, AD Lamb, B Hadaschik, ...
Prostate cancer and prostatic diseases 23 (1), 62-65, 2020
772020
Biochemical recurrence of prostate cancer: initial results with [18F] PSMA-1007 PET/CT
FL Giesel, L Will, C Kesch, M Freitag, C Kremer, J Merkle, OC Neels, ...
Journal of Nuclear Medicine 59 (4), 632-635, 2018
612018
Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients
A Borkowetz, B Hadaschik, I Platzek, M Toma, G Torsev, T Renner, ...
BJU international 121 (1), 53-60, 2018
602018
The system can't perform the operation now. Try again later.
Articles 1–20